The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients.

Lindsay A RitterNoel BrittonEmily L HeilWilliam A TeeterSarah B MurthiJonathan H ChowEmily RicottaDaniel S ChertowAlison GrazioliAndrea R Levine

Published in: Journal of intensive care medicine (2021)

Corticosteroids are an important and lifesaving pharmacotherapeutic option in critically ill patients with COVID-19, which have no impact on the likelihood of developing secondary infections.

Keyphrases

sars cov
cardiovascular events
risk factors
type diabetes
coronary artery disease